Amryt Pharma Limited
Activities of head offices · London
ActiveUnited KingdomIncorporated 2019Private Limited Company
Financial position
Accounts to 2025-12-31 · USD · Company accounts
Net assets
USD 558,579,000
Cash
USD 6,625,000
Turnover
USD 49,000
Profit / loss
−USD 2,513,000
Current assets
USD 35,717,000
Creditors < 1 year
USD 31,785,000
Equity
USD 558,579,000
Average employees
0
Balance-sheet trend
USD · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-31Company · AI-read | 2024-12-31Company · AI-read |
|---|---|---|
| Balance sheet | ||
| Net assets | USD 558,579,000 | USD 848,044,000 |
| Equity | USD 558,579,000 | USD 848,044,000 |
| Share capital | USD 29,142,000 | USD 29,142,000 |
| Retained earnings | USD 90,985,000 | −USD 22,294,000 |
| Assets | ||
| Fixed assets | USD 554,647,000 | USD 870,895,000 |
| Investments | USD 554,647,000 | USD 870,895,000 |
| Current assets | USD 35,717,000 | USD 4,065,000 |
| Cash at bank | USD 6,625,000 | USD 3,342,000 |
| Debtors | USD 29,092,000 | USD 723,000 |
| Liabilities | ||
| Creditors within one year | USD 31,785,000 | USD 26,916,000 |
| Net current assets | USD 3,932,000 | −USD 22,851,000 |
| Profit & loss | ||
| Turnover | USD 49,000 | USD 264,000 |
| Administrative expenses | USD 1,989,000 | USD 101,000 |
| Operating profit | −USD 1,940,000 | USD 282,000 |
| Interest payable | USD 573,000 | USD 2,435,000 |
| Profit before tax | −USD 2,513,000 | −USD 2,153,000 |
| Profit / loss | −USD 2,513,000 | −USD 2,153,000 |
| People & pay | ||
| Average employees | 0 | 0 |
| Source evidence | View filing | View filing |
From the accounts
What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.
- Auditor
- Deloitte Ireland LLP
- Audit opinion
- Clean (unmodified)
- Immediate parent
- Chiesi Farmaceutici SpA
- Ultimate parent
- Valline Srl
- Ultimate controlling party
- Valline Srl
- Accounts
- FRS 101
- Approved
- 2026-04-29, signed by Matthew Wiggetts
Related parties (4)
- Group Companies · Group companies · Management services provided · 49 (000s)
- Group Companies · Group companies · Management services provided · 264 (000s)
- Group Companies · Group companies · Amounts due to group companies · 31,827 (000s)
- Group Companies · Group companies · Amounts due to group companies · 25,796 (000s)
Share classes (4)
- 366,813,505 Ordinary shares of £0.06
- 366,813,517 Ordinary shares of £0.06
- — Treasury shares of £0.06
- — Treasury shares of £0.06
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesShow 3 satisfied / released
Fixed · created 2022-02-18 · satisfied 2023-04-19
—
SatisfiedAll Assets · created 2022-02-18 · satisfied 2023-04-19
—
SatisfiedAll Assets · created 2019-09-24 · satisfied 2022-03-02
—
Satisfied